Belumosudil Reference Standard
Parent: Belumosudil
N-Isopropyl-2-(3-(4-((1-nitroso-1H-indazol-5-yl)amino)quinazolin-2-yl)phenoxy)acetamide
Parent: Belumosudil
N-Isopropyl-2-(3-(4-oxo-4,4a-dihydroquinazolin-2-yl)phenoxy)acetamide
Parent: Belumosudil
2-(3-(4-((1H-indazol-5-yl)(nitroso)amino)quinazolin-2-yl)phenoxy)-N-isopropylacetamide
Parent: Belumosudil
2-(3-(4-((1H-Indazol-5-yl)amino)quinazolin-2-yl)phenoxy)acetic Acid
Parent: Belumosudil
Belumosudil Related Compound
Impurities in Belumosudil arise from its multi-step small molecule synthesis, which involves heterocyclic ring formation, halogenation, amide coupling, and selective substitutions. Due to its complexity and long synthesis, impurities—especially genotoxic and structural isomers—require careful control in accordance with ICH Q3A/B and ICH M7 guidelines.
Types of Impurities in Belumosudil
Process-Related Impurities
• Unreacted intermediates such as substituted pyrimidines or aminopyridines
• By-products from acylation, halogenation, or ring formation steps
• Residual reagents like EDC, HOBt, or coupling agents
• Residual solvents such as DCM, methanol, or DMF
• Isomeric or positional analogs from uncontrolled substitution patterns
Degradation Impurities
• Hydrolysis of the amide bond under acidic or basic conditions
• Oxidation of the aromatic or heterocyclic rings
• Light- or heat-induced rearrangement or degradation
• Formation of deschloro or hydroxylated derivatives
Elemental Impurities
• Trace metals such as palladium, copper, or iron from catalytic or synthetic steps
• Controlled under ICH Q3D limits for oral drug products
Analytical Techniques for Impurity Detection
- HPLC – main method for assay and related substance profiling
• LC-MS/MS – for identification of unknown impurities and structural elucidation
• GC – for quantification of residual solvents
• ICP-MS – for elemental impurity determination
• Photostability testing (ICH Q1B) – due to possible light sensitivity of heteroaromatics
• Forced degradation studies (ICH Q1A) – to characterize degradation pathways
FAQ
Belumosudil is used for the treatment of chronic graft-versus-host disease (cGVHD) in patients who have failed at least two previous systemic treatments.
It inhibits ROCK2, a kinase involved in immune regulation and fibrosis, thereby reducing inflammation, fibrotic tissue remodeling, and cytokine production.
- Fatigue
• Diarrhea
• Nausea
• Headache
• Elevated liver enzymes
Yes. It is a targeted small molecule inhibitor specifically designed to modulate ROCK2 signaling pathways.
Store at room temperature (20–25°C), protected from moisture and light. Keep in the original container until use.